News

New DR store ‘ups’ up market

BY DSN STAFF

NEW YORK — Duane Reade has further developed its leading edge “up market” store concept with the recent opening of its second flagship store in Manhattan’s Financial District. Located in the stately American Surety building at 100 Broadway, the 22,000-sq.-ft. store fits the rich history of the area while incorporating some of the most innovative ideas seen today in retail pharmacy.


This impressive location, which features a Walgreens bridge pharmacy — now in all 253 Duane Reade stores — caters to a mix of local workers and tourists. While the store may not feature many of the beauty-oriented services offered at 40 Wall St., it does offer several new additions in food, including a gourmet salad bar, full-time coffee barista and self-serve hot soups. The store also hosts a museum-like exhibit that pays homage to the many victory parades that have passed before it through Manhattan’s historic “Canyon of Heroes” section of lower Broadway.

Click here for part 1 of the photos.

Click here for part 2 of the photos.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Clampdown on the Rx gray market: Striking a balance amid drug shortages

BY Jim Frederick

How can Congress plug the leaks in the pharmaceutical supply chain and dry up the stream of gray market drugs without making the current drug shortage even worse? And can federal regulators shut down gray market profiteers without limiting “the ability of pharmacies to take care of their patients?”

That was the challenge posed by John Coster, SVP government affairs for the National Community Pharmacists Association, in testimony on July 25 before the Senate Committee on Commerce, Science and Transportation. The NCPA, like other pharmacy groups, supports a federal clampdown on unscrupulous "shell pharmacies … that seem to have been established for the sole purpose of buying medications in short supply from primary wholesalers in order to sell them to seemingly unethical secondary wholesalers," in Coster’s words. But he urged Congress not to apply a regulatory sledge hammer to the problem.

"Pharmacies should … be allowed to continue selling pharmaceutical products to other pharmacies, because it helps to alleviate temporary shortages, especially in rural areas where daily wholesaler deliveries may be more sporadic," Coster told the committee. And pharmacies serving every channel, including community drug stores and hospitals, should be free to use secondary wholesalers "as alternatives to ensure their inventory remains properly stocked," he warned.

Coster noted that the prescription drug shortages plaguing the nation’s health system "have been most acute at hospitals with relation to injectable and infusion drugs." The gray market purveyors skillfully are playing into those shortages, and in some cases, are holding hospitals hostage by exploiting their devotion to their primary mission: To put patients’ wellbeing and treatment priorities above all other considerations.

"Even within a budget, patient care trumps budgets," one pharmacy administrator for a hospital group in the upper Midwest told me. Another pharmacy manager at the same health system told me that the direct costs of having to use alternate suppliers for some scarce medicines range from $25,000 to $50,000 or more a month.

Another hospital pharmacy leader for a health system on the West Coast told me that the shortage has made gray market suppliers "very tempting because of clinical needs," but adds that she avoids that alternative supply channel. What stops her, she said, are concerns over a gray market drug’s pedigree and the fact that those products are sometimes "five times more than we normally pay."

The drug supply crunch is particularly serious for sterile injectables and infused medicines in such treatment areas as "pain medication, anesthesia, cancer care, emergency care — all the drugs related to surgeries," said Roslyne Schulman, director of policy for the American Hospital Association. The AHA polled more than 800 hospitals last year and found that virtually all of them were affected by one or more drug shortages in the first half of 2011, and that 82% of hospitals had “delayed patient treatment as a result of a drug shortage.” Schulman called that finding “stunning” and “record-breaking.”

What’s more, "The vast majority of all types of hospitals reported increased drug costs as a result of drug shortages," AHA reports, as they’ve resorted to buying more expensive alternative drugs from secondary sources.

As Drug Store News senior editor Mike Johnsen reports, the sellers can jack up the prices of drugs in critically short supply, sometimes by many multiples of their original price. And hospital pharmacy buyers sometimes feel they have little choice but to pay the exorbitant costs to get critically needed meds to their patients.

If you’re a hospital pharmacist trying to cope with the drug shortage, I’d like to hear from you. Have you had to routinely turn to secondary or even gray-market sources to plug the holes on your pharmacy’s shelves? And are you concerned that a clampdown on the gray market also could negatively impact the availability of needed medicines from even legitimate secondary suppliers?

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Lip Smacker turning 40

BY Antoinette Alexander

WESTLAKE, Ohio — Lip Smacker is celebrating its 40th anniversary next year with an array of limited-edition flavors and promotions.

The Bonne Bell Co. made headlines in 1973 when it introduced Lip Smacker and created the flavored lip gloss category. While there are many Lip Smacker flavors sold worldwide today, the first fruity flavor to hit the market was strawberry.

Named by Jesse Bell, former CEO of The Bonne Bell Co., it was originally made as a lip gloss for the outdoor person, but there was no flavoring. In order to be different, the company’s chemists formulated the first flavored Lip Smacker. The Bonne Bell Co. became the first company to distribute a lip product of this type. Not only was the flavor innovative but also the stick size and concentration of the flavor were a first in the industry.

To celebrate its 40th anniversary, the company will roll out new limited-edition flavors, strawberry and cupcake lover collections, special consumer value promotions, as well as QR code links to historical ads, Lip Smacker trivia, monthly sweepstakes, special social media events and more.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?